# TMED6

## Overview
TMED6, or transmembrane p24 trafficking protein 6, is a gene that encodes a type I single-pass transmembrane protein belonging to the p24 family, which is integral to the secretory pathway. The protein plays a pivotal role in vesicle assembling and trafficking, particularly in the early secretory pathway, where it facilitates the transport of proteins from the endoplasmic reticulum to the Golgi apparatus. TMED6 is characterized by a luminal Golgi-dynamics (GOLD) domain, a coiled-coil domain, a transmembrane domain, and a cytosolic tail, which are essential for its function in vesicle formation and cargo selection (Aber2019Transmembrane). Notably, TMED6 is highly expressed in pancreatic islet cells, where it is crucial for insulin secretion, and its dysregulation has been linked to the pathogenesis of type 2 diabetes (Wang2012Transmembrane; Van2022RNA). The protein's interactions with coatomer proteins and its potential as a target for RNA aptamers underscore its significance in both cellular transport mechanisms and therapeutic applications (Van2022RNA).

## Structure
TMED6, or transmembrane p24 trafficking protein 6, is a type I single-pass transmembrane protein that is part of the TMED family, which is involved in protein transport within the secretory pathway. The protein is characterized by a common structural organization that includes a luminal Golgi-dynamics (GOLD) domain, a luminal coiled-coil domain, a transmembrane domain, and a short cytosolic tail (Aber2019Transmembrane). The GOLD domain is crucial for dimerization, while the transmembrane domain interacts with lipids to facilitate vesicle budding. The cytoplasmic tail contains motifs important for binding to coatomer (COP) proteins, which are essential for cargo selection and vesicle formation (Aber2019Transmembrane).

TMED6 is also involved in vesicle assembling and trafficking, particularly in pancreatic islet cells, where its expression is linked to insulin secretion (Van2022RNA). The protein may undergo post-translational modifications such as glycosylation, as suggested by the presence of potential N-glycosylation sites exterior to the GOLD domain (Fiedler2016The). However, specific details about the tertiary and quaternary structures of TMED6 are not provided in the available literature.

## Function
TMED6, or transmembrane p24 trafficking protein 6, is a type 1 transmembrane protein that plays a crucial role in vesicle assembling and trafficking within cells. It is part of the p24 family, which is involved in the early secretory pathway, facilitating the transport of secretory proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. TMED6 is integral to the formation of COPI-coated vesicles, which are essential for retrograde transport, and interacts with the COPII coat to deliver cargo into budding transport vesicles (Schuiki2012Diverse).

In the pancreas, TMED6 is highly expressed, particularly in pancreatic islets, and is involved in the regulation of insulin secretion. It is predominantly found in α cells, with some expression in β cells, and its proper function is necessary for maintaining glucose homeostasis. Knockdown studies in mouse pancreatic β cells have shown that reduced TMED6 expression leads to decreased insulin secretion, highlighting its role in insulin vesicle control (Wang2012Transmembrane; Aber2019Transmembrane).

TMED6's expression is notably higher in the pancreas compared to other tissues, indicating its specialized function in this organ. Its dysregulation has been associated with the development of type 2 diabetes, as observed in diabetic rat models and human studies (Wang2012Transmembrane; Van2022RNA).

## Clinical Significance
TMED6 has been implicated in the regulation of insulin secretion and the development of diabetes. Alterations in TMED6 expression are associated with impaired insulin secretion and hyperglycemia, particularly in the context of type 2 diabetes. Studies have shown that TMED6 expression is significantly reduced in diabetic Goto-Kakizaki rats, a model for type 2 diabetes, which correlates with the development of moderate hyperglycemia and impaired insulin secretion (Wang2012Transmembrane; Aber2019Transmembrane). In human pancreatic islets, TMED6 expression is lower in patients with type 2 diabetes compared to healthy controls, suggesting its importance in maintaining normal pancreatic function and insulin secretion (Aber2019Transmembrane).

Research has also explored the potential of using RNA aptamers targeting TMED6 for therapeutic applications. These aptamers can facilitate the targeted delivery of imaging reagents and RNA therapeutics to human β cells, potentially improving the outcomes of islet transplantation by reducing early graft loss (Van2022RNA). The specificity of these aptamers for TMED6 highlights its potential as a therapeutic target in diabetes treatment (Van2022RNA). However, the clinical significance of TMED6 gene expression alterations in other diseases remains to be fully elucidated.

## Interactions
TMED6, or transmembrane p24 trafficking protein 6, is involved in vesicular trafficking and is part of the p24 family, which participates in the formation of COPI and COPII vesicles. These proteins often interact with other p24 family members and coat proteins, playing a role in the secretory pathway. TMED6 has been identified as a target for RNA aptamers, specifically aptamer 1-717, which binds to TMED6 with high specificity. This interaction has been validated using surface plasmon resonance assays, indicating a strong affinity in the nanomolar range (Van2022RNA).

In the context of pancreatic islets, TMED6 is suggested to play a regulatory role in vesicle assembling and trafficking, particularly in relation to insulin secretion. Silencing TMED6 has been shown to drastically reduce insulin secretion in MIN6 cells, highlighting its potential role in controlling insulin vesicles (Van2022RNA). The interaction of TMED6 with RNA aptamers has been utilized for targeted delivery of imaging reagents and RNA therapeutics to human β cells, demonstrating its involvement in therapeutic applications (Van2022RNA).


## References


[1. (Schuiki2012Diverse) Irmgard Schuiki and Allen Volchuk. Diverse roles for the p24 family of proteins in eukaryotic cells. BioMolecular Concepts, 3(6):561–570, December 2012. URL: http://dx.doi.org/10.1515/bmc-2012-0028, doi:10.1515/bmc-2012-0028. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/bmc-2012-0028)

[2. (Aber2019Transmembrane) Rachel Aber, Wesley Chan, Sevane Mugisha, and Loydie A. Jerome-Majewska. Transmembrane emp24 domain proteins in development and disease. Genetics Research, 2019. URL: http://dx.doi.org/10.1017/s0016672319000090, doi:10.1017/s0016672319000090. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1017/s0016672319000090)

[3. (Wang2012Transmembrane) Xiaochun Wang, Rongze Yang, Sanjay B. Jadhao, Daozhan Yu, Hong Hu, Nicole Glynn-Cunningham, Carole Sztalryd, Kristi D. Silver, and Da-Wei Gong. Transmembrane emp24 protein transport domain 6 is selectively expressed in pancreatic islets and implicated in insulin secretion and diabetes. Pancreas, 41(1):10–14, January 2012. URL: http://dx.doi.org/10.1097/mpa.0b013e318223c7e4, doi:10.1097/mpa.0b013e318223c7e4. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/mpa.0b013e318223c7e4)

[4. (Van2022RNA) Dimitri Van Simaeys, Adriana De La Fuente, Serena Zilio, Alessia Zoso, Victoria Kuznetsova, Oscar Alcazar, Peter Buchwald, Andrea Grilli, Jimmy Caroli, Silvio Bicciato, and Paolo Serafini. Rna aptamers specific for transmembrane p24 trafficking protein 6 and clusterin for the targeted delivery of imaging reagents and rna therapeutics to human β cells. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29377-3, doi:10.1038/s41467-022-29377-3. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29377-3)

5. (Fiedler2016The) The Wnt segment polarity pathway and TMED2 protein may interact via a lectin- and decoy-type mechanism. This article has 1 citations.